116 related articles for article (PubMed ID: 15779297)
1. [MMP-26 mRNA and estrogen receptor alpha co-expression in normal and pathological endometrium].
Pilka R; Kudela M; Eriksson P; Casslén B
Ceska Gynekol; 2005 Jan; 70(1):56-62. PubMed ID: 15779297
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinase-26 (matrilysin-2) expression is high in endometrial hyperplasia and decreases with loss of histological differentiation in endometrial cancer.
Pilka R; Norata GD; Domanski H; Andersson C; Hansson S; Eriksson P; Casslén B
Gynecol Oncol; 2004 Sep; 94(3):661-70. PubMed ID: 15350356
[TBL] [Abstract][Full Text] [Related]
3. Endometrial TIMP-4 mRNA is high at midcycle and in hyperplasia, but down-regulated in malignant tumours. Coordinated expression with MMP-26.
Pilka R; Domanski H; Hansson S; Eriksson P; Casslén B
Mol Hum Reprod; 2004 Sep; 10(9):641-50. PubMed ID: 15273280
[TBL] [Abstract][Full Text] [Related]
4. [Endometrial expression profiles of mRNA for selected matrix metalloproteinases and tissue inhibitor of metalloproteinases-1].
Pilka R; Kudela M; Eriksson P; Casslén B
Ceska Gynekol; 2004 Nov; 69(6):472-6. PubMed ID: 15633417
[TBL] [Abstract][Full Text] [Related]
5. [Novel matrix metalloproteinases in cycling endometrium].
Pilka R; Kudela M; Hansson S; Casslén B
Ceska Gynekol; 2004 Jul; 69(4):262-6. PubMed ID: 15369243
[TBL] [Abstract][Full Text] [Related]
6. [MMP-26 expression in endometrial explants treated with estradiol and progesterone].
Pilka R; Kudela M; Hansson S; Casslén B
Ceska Gynekol; 2004 Nov; 69(6):467-71. PubMed ID: 15633416
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical analysis of c-myc, c-jun and estrogen receptor in normal, hyperplastic and neoplastic endometrium.
Bircan S; Ensari A; Ozturk S; Erdogan N; Dundar I; Ortac F
Pathol Oncol Res; 2005; 11(1):32-9. PubMed ID: 15800680
[TBL] [Abstract][Full Text] [Related]
8. Significance of matrix metalloproteinase-7 [correction of matrix metalloproteinase-2], -11 and tissue inhibitor of metalloproteinase-1 expression in normal, hyperplastic and neoplastic endometrium.
Obokata A; Watanabe J; Nishimura Y; Arai T; Kawaguchi M; Kuramoto H
Anticancer Res; 2007; 27(1A):95-105. PubMed ID: 17352221
[TBL] [Abstract][Full Text] [Related]
9. Estrogen and estrogen receptor induce matrix metalloproteinase-26 expression in endometrial carcinoma cells.
Nishi H; Kuroda M; Isaka K
Oncol Rep; 2013 Aug; 30(2):751-6. PubMed ID: 23754174
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinase-26 is expressed in human endometrium but not in endometrial carcinoma.
Isaka K; Nishi H; Nakai H; Nakada T; Feng Li Y; Ebihara Y; Takayama M
Cancer; 2003 Jan; 97(1):79-89. PubMed ID: 12491508
[TBL] [Abstract][Full Text] [Related]
11. Coexpression index of estrogen receptor alpha mRNA isoforms in simple, complex hyperplasia without atypia, complex atypical hyperplasia and adenocarcinoma.
Witek A; Paul-Samojedny M; Stojko R; Seifert B; Mazurek U
Gynecol Oncol; 2007 Aug; 106(2):407-12. PubMed ID: 17561234
[TBL] [Abstract][Full Text] [Related]
12. Localization of MT1-MMP, TIMP-1, TIMP-2, and TIMP-3 messenger RNA in normal, hyperplastic, and neoplastic endometrium. Enhanced expression by endometrial adenocarcinomas is associated with low differentiation.
Määttä M; Soini Y; Liakka A; Autio-Harmainen H
Am J Clin Pathol; 2000 Sep; 114(3):402-11. PubMed ID: 10989641
[TBL] [Abstract][Full Text] [Related]
13. Metalloproteinase-2, -7 and -9 and tissue inhibitor of metalloproteinase-1 and -2 expression in normal, hyperplastic and neoplastic endometrium: a clinical-pathological correlation study.
Graesslin O; Cortez A; Fauvet R; Lorenzato M; Birembaut P; Daraï E
Ann Oncol; 2006 Apr; 17(4):637-45. PubMed ID: 16407419
[TBL] [Abstract][Full Text] [Related]
14. Expression of receptor-binding cancer antigen expressed on SiSo cells and estrogen receptor subtypes in the normal, hyperplastic, and carcinomatous endometrium.
Zhou XH; Teng XD; Song WY; Wu YJ
Int J Gynecol Cancer; 2008; 18(1):152-8. PubMed ID: 17466050
[TBL] [Abstract][Full Text] [Related]
15. Enhanced CD24 expression in endometrial carcinoma and its expression pattern in normal and hyperplastic endometrium.
Kim KH; Choi JS; Kim JM; Choi YL; Shin YK; Lee HC; Seong IO; Kim BK; Chae SW; Kim SH
Histol Histopathol; 2009 Mar; 24(3):309-16. PubMed ID: 19130400
[TBL] [Abstract][Full Text] [Related]
16. Epithelial expression of matrix metalloproteinase-26 is elevated at mid-cycle in the human endometrium.
Pilka R; Whatling C; Domanski H; Hansson S; Eriksson P; Casslén B
Mol Hum Reprod; 2003 May; 9(5):271-7. PubMed ID: 12728020
[TBL] [Abstract][Full Text] [Related]
17. Localization and hormonal regulation of endometrial matrix metalloproteinase-26 in the rhesus macaque.
Almeida-Francia CC; Keator CS; Mah K; Holden L; Hergert C; Slayden OD
Hum Reprod; 2012 Jun; 27(6):1723-34. PubMed ID: 22434853
[TBL] [Abstract][Full Text] [Related]
18. Expression of hyaluronic acid and its receptors, CD44s and CD44v6, in normal, hyperplastic, and neoplastic endometrium.
Afify AM; Craig S; Paulino AF; Stern R
Ann Diagn Pathol; 2005 Dec; 9(6):312-8. PubMed ID: 16308159
[TBL] [Abstract][Full Text] [Related]
19. Endometrial TIMP-4 mRNA is expressed in the stroma, while TIMP-4 protein accumulates in the epithelium and is released to the uterine fluid.
Pilka R; Noskova V; Domanski H; Andersson C; Hansson S; Casslén B
Mol Hum Reprod; 2006 Aug; 12(8):497-503. PubMed ID: 16809379
[TBL] [Abstract][Full Text] [Related]
20. Cathepsin D expression in normal, hyperplastic and malignant endometrial tissue: an immunohistochemical analysis.
Mylonas I; Makovitzky J; Richter DU; Jeschke U; Briese V; Friese K
Acta Histochem; 2003; 105(3):245-52. PubMed ID: 13677618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
